Serum MT1M and MT1G promoter methylation in HCC was greatly correlated with vascular invasion and distant metastases, serving as potential biomarkers (Ji et al., 2014; Zeng et al., 2018). This evidence concerns the gene MT1M and hepatocellular carcinoma.